Search

Search Constraints

You searched for: Author/Creator Gross, Chloe

Search Results

1. 1297. Characteristics for PrEP Uptake, Retention, and Discontinuation: Data From the ANCHOR Study. (26th November 2018)

3. Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs. (3rd February 2020)

4. Effect of HIV co-infection on adherence to a 12-week regimen of hepatitis C virus therapy with ledipasvir and sofosbuvir. (January 2016)

6. Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C Treatment. Issue 1 (5th January 2022)

7. Initiation of Low-threshold Buprenorphine in Nontreatment Seeking Patients With Opioid Use Disorder Engaged in Hepatitis C Treatment. Issue 1 (January 2022)

8. Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study. Issue 9 (September 2015)

9. Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study. Issue 9 (September 2015)

10. Long-Term Changes in Hepatic Fibrosis following Hepatitis C Viral Clearance in Patients with and without HIV. Issue 6 (August 2019)